January 2024
Civica by the Numbers
Delivering vital medications
160M
vials or syringesof essential
generic medications
to treat over
70M
patientsSolving critical drug shortages
~80
Genericmedications
available
from Civica
Building innovative partnerships
55+
Health System Members14
Manufacturing PartnersJanuary 1, 2024
Becker’s Healthcare Podcast Featuring Civica Board Chairman Dan Liljenquist
Recorded live at the 11th Annual Becker’s Healthcare CEO + CFO Roundtable, Dan Liljenquist, Chief Strategy Officer at Intermountain Healthcare and Board Chair at Civica Rx, discussed the issues around increased denials, the shifting regulatory landscape and more.
January 31, 2024
Podnosis: Catching up with the Fierce 15 of 2019
This episode of “Podnosis” rewinds to January 2019 when Fierce Healthcare unveiled its inaugural Fierce 15, spotlighting 15 private companies engaged in pioneering work and making waves in healthcare innovation. Hear from Civica Rx CEO Ned McCoy about Civica Rx’s journey.
February 6, 2024
Civica’s Allan Coukell Talks about Drug Shortages at a 2024 US House Committee on Ways and Means Hearing
View video excerpts from the U.S. House Committee on Ways & Means hearing on drug shortages, including Civica Rx’s Allan Coukell’s opening comments and responses to numerous questions from members of the Committee. Participants discussed drug shortages for four hours, addressing causes of shortages, potential policy-related solutions and the overall impact on patients.
Media Coverage
February 6, 2024
Podcast: How Hospitals are Helping Tackle the Drug Shortage Crisis
Hear from Civica’s Chief Government Affairs and Public Policy Officer Allan Coukell about the state of hospital drug shortages in the U.S. today and how Civica’s non-profit model and policy solutions are tackling the issues and bringing stability to the market.
March 4, 2024
CivicaScript: Using the Healthcare Utility Model to Manage Pharmacy Cost for Patients and Payers
CivicaScript, along with members Blue Shield of California and Lumicera Health Services, is featured in Managed Healthcare Executive, showcasing the good that can happen when innovative, like-minded stakeholders work together to make generic medicines affordable and accessible to patients.
Media Coverage
March 22, 2024
Case Study – Civica, groninger and SKAN Partnering on Essential Medicines
Civica is the only pharmaceutical company created for the express purpose of preventing and mitigating drug shortages. We partnered with experienced market leaders groninger and SKAN to technologically equip our new Virginia facility. Learn more about our inspiring collaboration in this video.
April 25, 2024
Harvard Business Review: A Proven Model to Combat US Drug Shortages
Drug shortages have been a chronic problem in the U.S. for well over a decade. Today, drug shortages are at a record high with over 300 essential generic medications in short supply.
The “Civica model” is different from the traditional generic drug supply chain and could inspire improvements to the larger U.S. system.
Media Coverage
May 22, 2024
Podnosis: Hospitals Grapple with Generic Drug Supply Shortages
Civica Chief Government Affairs and Public Policy Officer Allan Coukell discusses how the Civica business model addresses drug shortages within hospitals, allowing them to serve patients more effectively, and how eliminating shortages reduces costs within hospitals.
May 28, 2024
Civica’s New High-value Filling Lines Produce Insulin and More
Civica is on a mission to deliver quality generic medicines – including insulin – at low cost. A new isolator-integrated vial filling line and nest filling line allow them to produce many different forms of injectables and to pivot based on greatest need.
Media Coverage
June 5, 2024
Drug Shortages are Lasting Longer, Driven by Economic Pressures
A U.S. Pharmacopeia report offers insight into the economic issues surrounding the record high number of drug shortages and efforts to combat the shortages.
Media Coverage
